Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.5150 (18.22%) ($5.0100 - $5.6650) on Mon. May. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.88% (three month average) | RSI | 76 | Latest Price | $5.5150(18.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 7.9% a day on average for past five trading days. | Weekly Trend | BCRX advances 14.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) IYT(8%) XLC(7%) UUP(5%) IGOV(4%) TBT(4%) | Factors Impacting BCRX price | BCRX will decline at least -4.94% in a week (0% probabilities). EWP(-6%) TLT(-5%) ONLN(-5%) GDXJ(-5%) VIXM(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.94% (StdDev 9.88%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.38(25.91%) | 10 Day Moving Average | $4.06(35.84%) | 20 Day Moving Average | $3.64(51.51%) | To recent high | 0% | To recent low | 0% | Market Cap | $973m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |